ROW Territory Agreement Sample Clauses

ROW Territory Agreement. The Parties hereby agree to prepare and cause to be entered into, no later than (30) days following the Effective Date, a separate written agreement incorporating the provisions herein relating to Collaboration Products (and all other relevant matters) in the ROW Territory (the “ROW Agreement”). The ROW Agreement will have the effect of amending this Agreement solely to the extent that the Parties’ rights and responsibilities shall be divided into two separate agreements: one relating to the US Territory and the other relating to the ROW Territory. The Parties to the ROW Agreement will be Shire Pharmaceuticals Ireland Limited (“SPIL”) and New River. For purposes of the initial license fee provided for in Section 7.1, Shire shall pay $48,800,000 of such amount for its own account and $1,200,000 for the account of SPIL. The milestone payments provided for in Section 7.2 (excluding the milestone payment provided for in Section 7.2(d)) will remain the sole responsibility of Shire. SPIL will be solely responsible for making the milestone payment provided for in Section 7.2(d) . [Signature Page Follows.]
AutoNDA by SimpleDocs

Related to ROW Territory Agreement

  • Regulatory Agreements List any exceptions to the representation and warranty in Section 2.19

  • Pharmacovigilance Agreement Within [***] after the Effective Date, BMS and the Company (under the guidance of their respective Pharmacovigilance Departments, or equivalent thereof) shall define and finalize the responsibilities the Parties shall employ to protect patients and promote their well-being in connection with the use of the Licensed Compound(s) until such time that all pharmacovigilance responsibilities have transferred from BMS to Company. These responsibilities shall include mutually acceptable guidelines and procedures for the receipt, investigation, recordation, communication, and exchange (as between the Parties) of adverse event reports, pregnancy reports, and any other information concerning the safety of any Licensed Compound(s). Such guidelines and procedures shall be in accordance with, and enable the Parties and their Affiliates to fulfill, local and international regulatory reporting obligations to government authorities. Furthermore, such agreed procedures shall be consistent with relevant International Council for Harmonization (ICH) guidelines, except where said guidelines may conflict with existing local regulatory safety reporting requirements, in which case local reporting requirements shall prevail. Until such guidelines and procedures are set forth in a written agreement between the Parties (hereafter referred to as the “Pharmacovigilance Agreement”), the Party responsible for pharmacovigilance prior to execution of this Agreement shall have sole Pharmacovigilance responsibility for the Licensed Compound(s) subject to all applicable regulations and guidelines. In the event that this Agreement is terminated, the Parties agree to implement the necessary procedures and practices to ensure that any outstanding pharmacovigilance reporting obligations are fulfilled. Certain information marked as [***] has been excluded from this exhibit because it is both (i) not material and (ii) would be competitively harmful if publicly disclosed.

  • Collaboration Agreement The Collaboration Agreement shall not have been terminated in accordance with its terms and shall be in full force and effect.

  • Marketing Agreement The Company shall have entered into, ------------------- executed and delivered the Marketing Agreement.

  • Manufacturing Agreement Each of the Sellers (as applicable) shall have executed and delivered to the Buyer the Manufacturing Agreement with respect to the portion of the Business conducted at the applicable Facility.

  • Development Agreement That certain Development Agreement dated of even date herewith by and between the Company and Developer providing for the development of the Project on the Property, a copy of which is attached hereto as Exhibit C and incorporated herein by reference. Development Fee. As described in Section 6.8.

  • License Agreement The Trust shall have the non-exclusive right to use the name "Invesco" to designate any current or future series of shares only so long as Invesco Advisers, Inc. serves as investment manager or adviser to the Trust with respect to such series of shares.

  • Xxxxxx Agreement Xxxx Agreement contains the entire agreement between the parties with respect to the subject matter hereof and supersedes all prior agreement, written or oral, with respect thereto.

  • Application to Master Agreement For the avoidance of doubt, Clause 21.5 does not apply in respect of sums due from the Borrower to the Swap Bank under or in connection with the Master Agreement as to which sums the provisions of section 8 (Contractual Currency) of the Master Agreement shall apply.

  • Supply Agreement Buyer shall have executed and delivered the Supply Agreement to the Company.

Time is Money Join Law Insider Premium to draft better contracts faster.